🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8323706

Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and t

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318666

Use of leptin to treat metabolic abnormalities associated with lipoatrophy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318425

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer

The United States of America, as Represented by the Secretary, Department of Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318183

Plasmodium liver stage antigens

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318177

Viral chemokine-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8313789

Methods of promoting the growth of beneficial bacteria in the gut

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8313746

Human monoclonal antibodies against hendra and nipah viruses

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8309701

Variants of human taste receptor genes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8309527

Immunomodulatory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8303960

Radiolabeled affibody molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8299050

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298546

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298541

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298525

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298523

Compositions containing interleukin-1 and peptides

United Technologies UT AG · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293800

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the tre

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293724

Therapeutic applications of fatty acid amide hydrolase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288530

Method of preparing macromolecular contrast agents and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288439

Methods and compositions for the inhibition of HIV-1 replication

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative l

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8287876

Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8282926

CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapept

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283151

Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted